C

조아제약

034940KOSDAQ의약품 제조업

45.1 / 100

Reference Date: 2026-06-10

Financial Score7.5 / 40
News Sentiment20.6 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 27.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Joa Pharmaceutical, established in 1988, primarily engages in the production and sale of general pharmaceuticals, health functional foods, and is developing pet pharmaceuticals and nutritional supplements. It operates a nationwide pharmacy franchise, Medipham, and supplies over 200 products, including liver disease treatment drug Hepatos, memory improvement drug Joa Baiton, and children's health beverage Jalketon. The company has been exporting its products to 23 countries, including Vietnam, China, and the U.S., since 1995.

Number of Employees

243people

Average Salary

62.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 11.934.0Point
PBR
0.92Industry Average 0.892.5Point

Higher than industry avg (caution)

ROE
-29.26Industry Average 4.010.0Point

Well below industry avg

Debt Ratio
32.88Industry Average 12.430.0Point

2.6x industry avg (risky)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼2.9% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼4.8% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -28.1% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 82.5

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 647Won52-week high 1,26952-week low 647
1-month return0.0Point

1m -27.30% (strong drop)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0
  • Neutral주주총회소집결의2026-05-22
  • Neutral주식병합결정2026-05-22
  • Neutral주주명부폐쇄기간또는기준일설정2026-05-22
  • Neutral분기보고서 (2026.03)2026-05-15